IP08-22: Radiographic Response to Neoadjuvant Therapy for Renal Cell Carcinoma Does Not Correlate to Pathologic Response Using Immune-related Residual Viable Tumor (irRVT)

IP08-22: Radiographic Response to Neoadjuvant Therapy for Renal Cell Carcinoma Does Not Correlate to Pathologic Response Using Immune-related Residual Viable Tumor (irRVT)

Friday, May 15, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)
146A
Abstract

Registered attendees

Alexander Kutikov
Alexander Kutikov
Chair, Urology and Urologic OncologyFox Chase Cancer Center
David Chen
David Chen
ProfessorFox Chase Cancer Center-Temple Health Urologic Institute
David Han
David Han
FellowFox Chase-Temple Urologic Institute

Log in

See all the content and easy-to-use features by logging in or registering!